| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Third Department of Internal Medicine, Yamanashi Medical University, Yamanashi 40938, Japan
Address all correspondence and requests for reprints to: Dr. T. Onaya, Third Department of Internal Medicine, Yamanashi Medical University, Tamaho, Yamanashi 40938, Japan. E-mail: onayat{at}res.yamanashi-med.ac.jp
To investigate the mechanism of I- transport
stimulation by TSH, we studied the effects of TSH on
Na+/I- symporter (NIS) messenger RNA
(mRNA) and protein levels in FRTL-5 cells and correlated these with
I- transport activity. When 1 mU/ml TSH was
added to quiescent FRTL-5 cells, a 12-h latency was observed before the
onset of increased I- transport activity, which
reached a maximum [
27 times basal (5H medium) levels] at 72
h. In contrast, Northern blot analysis, using rat NIS complementary DNA
as a probe, revealed that addition of TSH to these cells significantly
increased NIS mRNA at 36 h, reaching a maximum after 24 h
(
5.9 times basal levels). Forskolin and (Bu)2cAMP
mimicked this stimulatory effect on both the I-
transport activity and mRNA levels.
D-ribofranosylbenzimidazole, a transcription inhibitor,
almost completely blocked TSH-induced stimulation of
I- transport and NIS mRNA levels. Western blot
analysis demonstrated that TSH increased NIS protein levels at 36
h, reaching a maximum at 72 h, in parallel with the kinetics of
TSH-induced I- transport activity. However, it
also showed that the amount of NIS protein already present in FRTL-5
cell membranes before the addition of TSH was about one third of the
maximum level induced by TSH. These results indicate that stimulation
of I- transport activity by TSH in thyrocytes is
partly due to a rapid increase in NIS gene expression, followed by a
relatively slow NIS protein synthesis. However, the existence of an
abundant amount of protein in quiescent FRTL-5 cells with very low
I- transport activity also suggests that this
activity is controlled by another TSH-regulated factor(s).
This article has been cited by other articles:
![]() |
T. Kogai, E. Ohashi, M. S. Jacobs, S. Sajid-Crockett, M. L. Fisher, Y. Kanamoto, and G. A. Brent Retinoic Acid Stimulation of the Sodium/Iodide Symporter in MCF-7 Breast Cancer Cells Is Meditated by the Insulin Growth Factor-I/Phosphatidylinositol 3-Kinase and p38 Mitogen-Activated Protein Kinase Signaling Pathways J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1884 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Fenton, K. M. Marion, and J. M. Hershman Identification of Cyclic Adenosine 3',5'-Monophosphate Response Element Modulator as an Activator of the Human Sodium/Iodide Symporter Upstream Enhancer Endocrinology, May 1, 2008; 149(5): 2592 - 2606. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. McLanahan, M. E. Andersen, and J. W. Fisher A Biologically Based Dose-Response Model for Dietary Iodide and the Hypothalamic-Pituitary-Thyroid Axis in the Adult Rat: Evaluation of Iodide Deficiency Toxicol. Sci., April 1, 2008; 102(2): 241 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Giuliani, Y. Noguchi, N. Harii, G. Napolitano, D. Tatone, I. Bucci, M. Piantelli, F. Monaco, and L. D. Kohn The Flavonoid Quercetin Regulates Growth and Gene Expression in Rat FRTL-5 Thyroid Cells Endocrinology, January 1, 2008; 149(1): 84 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, K. Richard, B. McKinnon, and R. H. Mortimer Effect of Iodide on Human Choriogonadotropin, Sodium-Iodide Symporter Expression, and Iodide Uptake in BeWo Choriocarcinoma Cells J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4046 - 4051. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D Vadysirisack, A. Venkateswaran, Z. Zhang, and S. M Jhiang MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner Endocr. Relat. Cancer, June 1, 2007; 14(2): 421 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Lim, J. C. Paeng, S. J. Kim, S. Y. Kim, H. Lee, and D. H. Moon Enhanced Expression of Adenovirus-Mediated Sodium Iodide Symporter Gene in MCF-7 Breast Cancer Cells with Retinoic Acid Treatment J. Nucl. Med., March 1, 2007; 48(3): 398 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Rhoden, S. Cianchetta, V. Stivani, C. Portulano, L. J. V. Galietta, and G. Romeo Cell-based imaging of sodium iodide symporter activity with the yellow fluorescent protein variant YFP-H148Q/I152L Am J Physiol Cell Physiol, February 1, 2007; 292(2): C814 - C823. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Calebiro, T. de Filippis, S. Lucchi, F. Martinez, P. Porazzi, R. Trivellato, M. Locati, P. Beck-Peccoz, and L. Persani Selective Modulation of Protein Kinase A I and II Reveals Distinct Roles in Thyroid Cell Gene Expression and Growth Mol. Endocrinol., December 1, 2006; 20(12): 3196 - 3211. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Riesco-Eizaguirre and P. Santisteban A perspective view of sodium iodide symporter research and its clinical implications. Eur. J. Endocrinol., October 1, 2006; 155(4): 495 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Kogai, K Taki, and G A Brent Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 797 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Opitz, A. Trubiroha, C. Lorenz, I. Lutz, S. Hartmann, T. Blank, T. Braunbeck, and W. Kloas Expression of sodium-iodide symporter mRNA in the thyroid gland of Xenopus laevis tadpoles: developmental expression, effects of antithyroidal compounds, and regulation by TSH. J. Endocrinol., July 1, 2006; 190(1): 157 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki and L. D Kohn Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. J. Endocrinol., May 1, 2006; 189(2): 247 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bernier-Valentin, S. Trouttet-Masson, R. Rabilloud, S. Selmi-Ruby, and B. Rousset Three-Dimensional Organization of Thyroid Cells into Follicle Structures Is a Pivotal Factor in the Control of Sodium/Iodide Symporter Expression Endocrinology, April 1, 2006; 147(4): 2035 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pena, S. Arum, M. Cross, B. Magnani, E. N. Pearce, M. E. Oates, and L. E. Braverman 123I Thyroid Uptake and Thyroid Size at 24, 48, and 72 Hours after the Administration of Recombinant Human Thyroid-Stimulating Hormone to Normal Volunteers J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 506 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Jarzab, D Handkiewicz-Junak, and J Wloch Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review Endocr. Relat. Cancer, December 1, 2005; 12(4): 773 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garcia-Jimenez, M. A. Zaballos, and P. Santisteban DARPP-32 (Dopamine and 3',5'-Cyclic Adenosine Monophosphate-Regulated Neuronal Phosphoprotein) Is Essential for the Maintenance of Thyroid Differentiation Mol. Endocrinol., December 1, 2005; 19(12): 3060 - 3072. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kimura, S.-C. Tzou, R. Rocchi, M. Kimura, K. Suzuki, A. F. Parlow, N. R. Rose, and P. Caturegli Interleukin (IL)-12-Driven Primary Hypothyroidism: the Contrasting Roles of Two Th1 Cytokines (IL-12 and Interferon-{gamma}) Endocrinology, August 1, 2005; 146(8): 3642 - 3651. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kogai, Y. Kanamoto, A. I. Li, L. H. Che, E. Ohashi, K. Taki, R. A. Chandraratna, T. Saito, and G. A. Brent Differential Regulation of Sodium/Iodide Symporter Gene Expression by Nuclear Receptor Ligands in MCF-7 Breast Cancer Cells Endocrinology, July 1, 2005; 146(7): 3059 - 3069. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Frohlich, A. Witke, B. Czarnocka, and R. Wahl Retinol has specific effects on binding of thyrotrophin to cultured porcine thyrocytes J. Endocrinol., December 1, 2004; 183(3): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Chun, V. Di Dato, B. D'Andrea, M. Zannini, and R. Di Lauro The CRE-Like Element Inside the 5'-Upstream Region of the Rat Sodium/Iodide Symporter Gene Interacts with Diverse Classes of b-Zip Molecules that Regulate Transcriptional Activities through Strong Synergy with Pax-8 Mol. Endocrinol., November 1, 2004; 18(11): 2817 - 2829. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. De Felice, M. P. Postiglione, and R. Di Lauro Minireview: Thyrotropin Receptor Signaling in Development and Differentiation of the Thyroid Gland: Insights from Mouse Models and Human Diseases Endocrinology, September 1, 2004; 145(9): 4062 - 4067. [Full Text] [PDF] |
||||
![]() |
S. Trouttet-Masson, S. Selmi-Ruby, F. Bernier-Valentin, V. Porra, N. Berger-Dutrieux, M. Decaussin, J.-L. Peix, A. Perrin, C. Bournaud, J. Orgiazzi, et al. Evidence for Transcriptional and Posttranscriptional Alterations of the Sodium/Iodide Symporter Expression in Hypofunctioning Benign and Malignant Thyroid Tumors Am. J. Pathol., July 1, 2004; 165(1): 25 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Driedger and N. Kotowycz Two Cases of Thyroid Carcinoma That Were Not Stimulated by Recombinant Human Thyrotropin J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 585 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kogai, Y. Kanamoto, L. H. Che, K. Taki, F. Moatamed, J. J. Schultz, and G. A. Brent Systemic Retinoic Acid Treatment Induces Sodium/Iodide Symporter Expression and Radioiodide Uptake in Mouse Breast Cancer Models Cancer Res., January 1, 2004; 64(1): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pomerance, D. Carapau, F. Chantoux, M. Mockey, C. Correze, J. Francon, and J.-P. Blondeau CCAAT/Enhancer-Binding Protein-Homologous Protein Expression and Transcriptional Activity Are Regulated by 3',5'-Cyclic Adenosine Monophosphate in Thyroid Cells Mol. Endocrinol., November 1, 2003; 17(11): 2283 - 2294. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dohan, A. De la Vieja, V. Paroder, C. Riedel, M. Artani, M. Reed, C. S. Ginter, and N. Carrasco The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance Endocr. Rev., February 1, 2003; 24(1): 48 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Morand, O. F. Dos Santos, R. Ohayon, J. Kaniewski, M.-S. Noel-Hudson, A. Virion, and C. Dupuy Identification of a Truncated Dual Oxidase 2 (DUOX2) Messenger Ribonucleic Acid (mRNA) in Two Rat Thyroid Cell Lines. Insulin and Forskolin Regulation of DUOX2 mRNA Levels in FRTL-5 Cells and Porcine Thyrocytes Endocrinology, February 1, 2003; 144(2): 567 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Postiglione, R. Parlato, A. Rodriguez-Mallon, A. Rosica, P. Mithbaokar, M. Maresca, R. C. Marians, T. F. Davies, M. S. Zannini, M. De Felice, et al. Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland PNAS, November 26, 2002; 99(24): 15462 - 15467. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Taki, T. Kogai, Y. Kanamoto, J. M. Hershman, and G. A. Brent A Thyroid-Specific Far-Upstream Enhancer in the Human Sodium/Iodide Symporter Gene Requires Pax-8 Binding and Cyclic Adenosine 3',5'-Monophosphate Response Element-Like Sequence Binding Proteins for Full Activity and Is Differentially Regulated in Normal and Thyroid Cancer Cells Mol. Endocrinol., October 1, 2002; 16(10): 2266 - 2282. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pacini, E. Molinaro, M. G. Castagna, F. Lippi, C. Ceccarelli, L. Agate, R. Elisei, and A. Pinchera Ablation of Thyroid Residues with 30 mCi 131I: A Comparison in Thyroid Cancer Patients Prepared with Recombinant Human TSH or Thyroid Hormone Withdrawal J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4063 - 4068. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Garcia and P. Santisteban PI3K Is Involved in the IGF-I Inhibition of TSH-Induced Sodium/Iodide Symporter Gene Expression Mol. Endocrinol., February 1, 2002; 16(2): 342 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Castro, E. R. Bergert, J. R. Goellner, I. D. Hay, and J. C. Morris Immunohistochemical Analysis of Sodium Iodide Symporter Expression in Metastatic Differentiated Thyroid Cancer: Correlation with Radioiodine Uptake J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5627 - 5632. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kogai, J. M. Hershman, K. Motomura, T. Endo, T. Onaya, and G. A. Brent Differential Regulation of the Human Sodium/Iodide Symporter Gene Promoter in Papillary Thyroid Carcinoma Cell Lines and Normal Thyroid Cells Endocrinology, August 1, 2001; 142(8): 3369 - 3379. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spitzweg, K. J. Harrington, L. A. Pinke, R. G. Vile, and J. C. Morris The Sodium Iodide Symporter and Its Potential Role in Cancer Therapy J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3327 - 3335. [Full Text] [PDF] |
||||
![]() |
A. Iseki, F. Kambe, K. Okumura, T. Hayakawa, and H. Seo Regulation of Thyroid Follicular Cell Function by Intracellular Redox-Active Copper Endocrinology, December 1, 2000; 141(12): 4373 - 4382. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spitzweg, M. K. OConnor, E. R. Bergert, D. J. Tindall, C. Y. F. Young, and J. C. Morris Treatment of Prostate Cancer by Radioiodine Therapy after Tissue-specific Expression of the Sodium Iodide Symporter Cancer Res., November 1, 2000; 60(22): 6526 - 6530. [Abstract] [Full Text] |
||||
![]() |
D. A. Huysmans, W.-A. Nieuwlaat, R. J. Erdtsieck, A. P. Schellekens, J. W. Bus, B. Bravenboer, and A. R. Hermus Administration of a Single Low Dose of Recombinant Human Thyrotropin Significantly Enhances Thyroid Radioiodide Uptake in Nontoxic Nodular Goiter J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3592 - 3596. [Abstract] [Full Text] |
||||
![]() |
A. De la Vieja, O. Dohan, O. Levy, and N. Carrasco Molecular Analysis of the Sodium/Iodide Symporter: Impact on Thyroid and Extrathyroid Pathophysiology Physiol Rev, July 1, 2000; 80(3): 1083 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Furlanetto, L. Q. Nguyen, and J. L. Jameson Estradiol Increases Proliferation and Down-Regulates the Sodium/Iodide Symporter Gene in FRTL-5 Cells Endocrinology, December 1, 1999; 140(12): 5705 - 5711. [Abstract] [Full Text] |
||||
![]() |
K. Suzuki, A. Mori, J. Saito, E. Moriyama, L. Ullianich, and L. D. Kohn Follicular Thyroglobulin Suppresses Iodide Uptake by Suppressing Expression of the Sodium/Iodide Symporter Gene Endocrinology, November 1, 1999; 140(11): 5422 - 5430. [Abstract] [Full Text] |
||||
![]() |
P. H. K. Eng, G. R. Cardona, S.-L. Fang, M. Previti, S. Alex, N. Carrasco, W. W. Chin, and L. E. Braverman Escape from the Acute Wolff-Chaikoff Effect Is Associated with a Decrease in Thyroid Sodium/Iodide Symporter Messenger Ribonucleic Acid and Protein Endocrinology, August 1, 1999; 140(8): 3404 - 3410. [Abstract] [Full Text] |
||||
![]() |
M. Ohno, M. Zannini, O. Levy, N. Carrasco, and R. di Lauro The Paired-Domain Transcription Factor Pax8 Binds to the Upstream Enhancer of the Rat Sodium/Iodide Symporter Gene and Participates in Both Thyroid-Specific and Cyclic-AMP-Dependent Transcription Mol. Cell. Biol., March 1, 1999; 19(3): 2051 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Caillou, F. Troalen, E. Baudin, M. Talbot, S. Filetti, M. Schlumberger, and J.-M. Bidart Na+/I- Symporter Distribution in Human Thyroid Tissues: An Immunohistochemical Study J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4102 - 4106. [Abstract] [Full Text] |
||||
![]() |
S. Kosugi, Y. Sato, A. Matsuda, Y. Ohyama, K. Fujieda, H. Inomata, T. Kameya, O. Isozaki, and S. M. Jhiang High Prevalence of T354P Sodium/Iodide Symporter Gene Mutation in Japanese Patients with Iodide Transport Defect Who Have Heterogeneous Clinical Pictures J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4123 - 4129. [Abstract] [Full Text] |
||||
![]() |
K.-Y. Ryu, Q. Tong, and S. M. Jhiang Promoter Characterization of the Human Na+/I- Symporter J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3247 - 3251. [Abstract] [Full Text] |
||||
![]() |
M. Ohmori, T. Endo, N. Harii, and T. Onaya A Novel Thyroid Transcription Factor Is Essential for Thyrotropin-Induced Up-Regulation of Na+/I- Symporter Gene Expression Mol. Endocrinol., May 1, 1998; 12(5): 727 - 736. [Abstract] [Full Text] |
||||
![]() |
A. E. Pekary, J. M. Hershman, and L. Berg Tumor Necrosis Factor, Ceramide, Transforming Growth Factor-{beta}1, and Aging Reduce Na+/I- Symporter Messenger Ribonucleic Acid Levels in FRTL-5 Cells Endocrinology, February 1, 1998; 139(2): 703 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsuda and S. Kosugi A Homozygous Missense Mutation of the Sodium/Iodide Symporter Gene Causing Iodide Transport Defect J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3966 - 3971. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, T. Endo, A. Kawaguchi, M. Ikeda, M. Nakazato, T. Kogai, and T. Onaya Increased Expression of the Na+/I- Symporter in Cultured Human Thyroid Cells Exposed to Thyrotropin and in Graves' Thyroid Tissue J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3331 - 3336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pomerance, H.-B. Abdullah, S. Kamerji, C. Correze, and J.-P. Blondeau Thyroid-stimulating Hormone and Cyclic AMP Activate p38 Mitogen-activated Protein Kinase Cascade. INVOLVEMENT OF PROTEIN KINASE A, Rac1, AND REACTIVE OXYGEN SPECIES J. Biol. Chem., December 15, 2000; 275(51): 40539 - 40546. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Riedel, O. Levy, and N. Carrasco Post-transcriptional Regulation of the Sodium/Iodide Symporter by Thyrotropin J. Biol. Chem., June 8, 2001; 276(24): 21458 - 21463. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kogai, J. J. Schultz, L. S. Johnson, M. Huang, and G. A. Brent Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line PNAS, July 18, 2000; 97(15): 8519 - 8524. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |